- Home
- BWFG vs GLSI Comparison
BWFG vs GLSI Comparison
Compare BWFG & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- GLSI
- Stock Information
- Founded
- BWFG 2002
- GLSI 2006
- Country
- BWFG United States
- GLSI United States
- Employees
- BWFG N/A
- GLSI N/A
- Industry
- BWFG Major Banks
- GLSI Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- GLSI Health Care
- Exchange
- BWFG Nasdaq
- GLSI Nasdaq
- Market Cap
- BWFG 341.5M
- GLSI 145.2M
- IPO Year
- BWFG N/A
- GLSI 2020
- Fundamental
- Price
- BWFG $43.45
- GLSI $8.23
- Analyst Decision
- BWFG Buy
- GLSI Strong Buy
- Analyst Count
- BWFG 2
- GLSI 1
- Target Price
- BWFG $53.00
- GLSI $39.00
- AVG Volume (30 Days)
- BWFG 21.3K
- GLSI 79.1K
- Earning Date
- BWFG 10-23-2025
- GLSI 11-14-2025
- Dividend Yield
- BWFG 1.84%
- GLSI N/A
- EPS Growth
- BWFG 88.52
- GLSI N/A
- EPS
- BWFG 3.66
- GLSI N/A
- Revenue
- BWFG $94,282,000.00
- GLSI N/A
- Revenue This Year
- BWFG $66.56
- GLSI N/A
- Revenue Next Year
- BWFG $14.45
- GLSI N/A
- P/E Ratio
- BWFG $11.85
- GLSI N/A
- Revenue Growth
- BWFG 30.93
- GLSI N/A
- 52 Week Low
- BWFG $26.39
- GLSI $8.01
- 52 Week High
- BWFG $48.03
- GLSI $15.47
- Technical
- Relative Strength Index (RSI)
- BWFG 50.58
- GLSI 31.41
- Support Level
- BWFG $42.50
- GLSI $8.02
- Resistance Level
- BWFG $43.95
- GLSI $9.51
- Average True Range (ATR)
- BWFG 1.28
- GLSI 0.54
- MACD
- BWFG 0.01
- GLSI -0.10
- Stochastic Oscillator
- BWFG 33.10
- GLSI 10.48
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.